Contact
Please use this form to send email to PR contact of this press release:
ABLYNX TO RECEIVE EU8 MILLION MILESTONE AS BOEHRINGER INGELHEIM STARTS FIRST PATIENT STUDY WITH A BI-SPECIFIC NANOBODY IN ONCOLOGY
TO:
Please use this form to send email to PR contact of this press release:
ABLYNX TO RECEIVE EU8 MILLION MILESTONE AS BOEHRINGER INGELHEIM STARTS FIRST PATIENT STUDY WITH A BI-SPECIFIC NANOBODY IN ONCOLOGY
TO: